| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5645200 | Annals of Allergy, Asthma & Immunology | 2017 | 7 Pages |
Abstract
Presence of splenomegaly, history of ITP or AIHA, low serum IgA level, and percentage expansion of CD21low B cells may be useful to identify a group of patients at high risk for development of GLILD.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Stella PhD, Megan S. MD, Shakila MD, Vilmarie MD, Vivek N. MD, MPH, Rohit MBBS, PhD, Avni Y. MD, MSc,